![]() |
市場調查報告書
商品編碼
1302938
全球旋轉閥市場 - 2023-2028 年預測Global Rotary Valve Market - Forecasts from 2023 to 2028 |
旋轉閥是一種通過旋轉橫向止動件中的通道來控制液體或氣體通過連接管道的流量的閥門。 旋轉閥最基本的類型是普通旋塞閥。 包括化工行業在內的各行業對節能產品的需求不斷增加,以及節水有益健康的意識不斷增強,都推動了旋轉閥市場的增長。 此外,由於疫情加劇,多個政府機構增加對製藥行業的投資也將推動預測期內旋轉閥市場的增長。
旋轉閥是化學工業中使用的主要部件之一,用作過程流體的控制閥、密封件和安全措施。 它還允許在各種壓力下進行無洩漏流量調節並提供靈活性。 化學工業產量的增加預計將推動旋轉閥市場的增長。 根據美國經濟分析局的數據,2021年化學工業為美國經濟貢獻了4400億美元。 根據網絡安全和基礎設施安全局(CISA)的數據,美國化學工業是全球第二大化學品生產國,全球13%的化學品來自美國。 化學工業生產市場的增長預計將推動旋轉閥市場的增長。
旋轉閥專為製藥和營養品行業的衛生研磨和粉碎應用而製造。 製藥行業中旋轉閥的用途是阻止和調節自由流動的材料。 旋轉閥可以均勻、連續地輸送粉末、顆粒或散裝材料。 製藥行業產量的增加預計將推動旋轉閥市場的增長。 國務院預計,2021年,我國醫藥業務收入預計將超過3.3萬億元,同比增長近20%。 據IBEF統計,2000年4月至2022年6月,印度製藥和醫療保健行業的直接投資總額約為199億美元。 根據同一份文件,印度的製藥業隨著時間的推移已經發展成為一個強大的行業,目前在藥品產量方面排名世界第三。 這表明製藥行業產量的增加將推動預測期內旋轉閥市場的增長。
由於製藥、食品和飲料行業等各個行業對旋轉閥應用的需求不斷增加,預計亞太地區將佔據主要市場份額。 亞洲製藥行業投資的增加預計將推動市場增長。 例如,根據印度品牌資產基金會的數據,2021 年 9 月,印度政府承諾向製藥和醫療保健行業提供約 40 億美元。 2019年7月,Cipla宣布與江蘇創諾藥業成立中國合資公司。 印度公司將擁有總投資3000萬美元的80%。 新業務將在中國建立一家製造工廠,生產呼吸產品。 政府和市場參與者對製藥行業投資的增加也推動了預測期內旋轉閥市場的增長。
A rotary valve is a type of valve in which the flow of liquid or gas through the connected pipes is controlled by rotating a passage in a transverse stopper. The most basic type of rotary valve is the common stopcock. Increased demand for energy-efficient products across various industries, including the chemical sector, and growing awareness of the health benefits of conserving water are fueling the growth of the rotary valve market. The growing investment in the pharmaceutical industry by several government bodies due to the increasing pandemic will also boost the growth of the global rotary valve market during the forecasted period.
The rotary valve is one of the key components used in the chemical industry, acting as a control valve, a seal, and a means of safety for process fluids. It also offers flexibility by allowing leak-free flow rate regulation at varied pressures. The growing production in the chemical industry will boost the rotary valve market growth. According to the US Bureau of Economic Analysis, the chemicals industry contributed $ 440 billion to the US economy in 2021. According to the Cybersecurity and Infrastructure Security Agency (CISA), The U.S. chemical industry is the world's second-largest chemical producer, with 13% of the world's chemicals coming from the United States. This growing chemical industry production market is anticipated to boost the global rotary valve market growth.
The rotary valve is specifically made for hygienic milling and micronization applications in the pharmaceutical and nutraceutical industries. The purpose of the rotary valve in the pharmaceutical industry is to stop and regulate free-flowing materials. They allow uniform dosing and continuous feeding of powders, granulates, or bulk materials. The growing production in the pharmaceutical industry will boost the rotary valve market growth. According to the State Council People's Republic of China, In 2021, China's pharmaceutical business will earn over 3.3 trillion yuan in revenue, indicating a nearly 20% increase year on year. According to IBEF, between April 2000 and June 2022, FDI investment into the Indian pharmaceutical and medicine sector totaled around US$19.90 billion. Also, as per the same source, the Indian pharmaceutical sector has developed over time into a robust and is currently rated third in the world in terms of pharmaceutical production volume. This shows that the growing production in the pharmaceutical sector will boost the global rotary valve market growth during the forecasted period.
The Asia Pacific region is anticipated to constitute a significant market share due to the growing demand for rotary valve applications in various sectors, including the pharmaceutical and food and beverage industries. The growing pharmaceutical industry investment in Asia is expected to boost market growth. For instance, In September 2021, according to the Indian Brand Equity Foundation, the Indian government contributed around $4 billion to the pharmaceutical and medical industry. In July 2019, Cipla announced the formation of a Chinese joint venture with Jiangsu Acebright Pharmaceutical. The Indian firm will own 80% of the total $30 million investment. The new business would establish a manufacturing plant in China to produce respiratory products. The growing pharmaceutical industry investments by the government and market players are also boosting the rotary valve market growth during the forecasted period.
Market Segmentation